Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum Acasti Pharma Inc ACST

Acasti Pharma Inc. is a Canada-based late-stage biopharma company with drug candidates addressing rare and orphan diseases. The Company is targeting three underserved orphan diseases: GTX-104, an intravenous infusion targeting subarachnoid hemorrhage (SAH), a rare and life-threatening medical emergency, in which bleeding occurs over the surface of the brain in the subarachnoid space between the... see more

NDAQ:ACST - Post Discussion

Acasti Pharma Inc > Be very careful
View:
Post by boozehound3 on May 22, 2020 5:20pm

Be very careful

Remember the Christmas massscre. Insider dumped 2 million shares.  You can bet they will have the inside track again as to the diabetic angle  just saying I have seen the bs with this stock so many times
Comment by sambelo on May 23, 2020 1:24am
This post has been removed in accordance with Community Policy
Comment by postie1 on May 23, 2020 6:25am
Traders suddenly buying or selling en masse just before news hits happens way too much. But we all know that it is just mere coincidence because we all know the industry has nothing but the finest of people involved in it. I am pretty sure these people realy care about other people. But no , I am not going to buy that bridge that is for sale !
Comment by wobbles on May 25, 2020 2:47am
To be honest, I hope that Acasti are the ones being very careful. Perhaps those old dogs can learn new tricks. I already made my bed investing in ACST, and I am lying in it. Biotech is a roller coaster, and in this particular ACST case I truly can't get off....not yet. I am waiting for my exit point. No panic (I'm not built that way, thankfully) but senses working overtime as the clock ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities